Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2025 Jun 30:rs.3.rs-6431257.
doi: 10.21203/rs.3.rs-6431257/v1.

KinoViz: A User-Friendly Web Application for High-Throughput Kinome Profiling Analysis and Visualization in Cancer Research

Affiliations

KinoViz: A User-Friendly Web Application for High-Throughput Kinome Profiling Analysis and Visualization in Cancer Research

Ehsan Saghapour et al. Res Sq. .

Abstract

Kinases, at the signaling level, dynamically mediate uncontrolled cellular growth, survival and other cancer supporting processes. This, paired with the inherent druggability of kinases, points to the importance of measuring kinase activity, and that of inhibitors against them, directly, and to analyze this accurately. High-throughput kinome profiling technologies, such as the PamStation®12, allow researchers to kinetically capture kinase activity, against a multitude of peptide targets simultaneously. Yet, the complex datasets produced often require advanced computational tools and bioinformatics expertise to properly analyze that are not intuitive or readily available. To address this gap, we developed KinoViz, a web-based application to simplify analysis and visualization of kinome array data. KinoViz offers a suite of interactive tools that enables users to upload raw peptide phosphorylation datasets and conduct in-depth analyses without the need for coding knowledge. Key features include modules for visualizing kinetic phosphorylation curves, identifying statistically significant peptide changes, exploring individual peptide profiles, and generating insightful visualizations such as heatmaps, network diagrams, and dimensionality reduction plots (PCA, UMAP). By making complex kinomic data more accessible and interpretable, KinoViz allows researchers to rapidly generate interactive visualizations and comparative analyses. We aim to expand KinoViz's analytical capabilities for more advanced use, including use in direct translational drug discovery.

Keywords: Ex Vivo Profling; Glioblastoma; Kinomics; Patient-derived xenografts.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest None declared.

Figures

Figure 1
Figure 1. Overview of the KinoViz web application interface and visualization modules.
(A) Data upload and preprocessing interface, featuring interactive AG Grid tables for data filtering and exploration. (B) Identification and ranking of peptides based on signal intensity, emphasizing peptides with the highest phosphorylation signals. (C) Visualization of kinetic phosphorylation patterns across multiple experimental cycles and exposure times. (D) Comparative phosphorylation intensity plots for selected peptides under different experimental conditions. (E) Heatmap illustrating hierarchical clustering patterns of peptide phosphorylation intensities across samples. (F) Dimensionality reduction analysis (principal component analysis, PCA) for exploration of global phosphorylation intensity patterns. (G) Peptide–peptide correlation network analysis demonstrating relationships and connectivity among peptide phosphorylation events. (H) Statistical summary module, including comparative bar charts highlighting the top phosphorylated peptides.

References

    1. Johnson JL, et al. An atlas of substrate specificities for the human serine/threonine kinome. Nature. 2023;613(7945):759–66. - PMC - PubMed
    1. Yaron-Barir TM et al. The intrinsic substrate specificity of the human tyrosine kinome. Nature, 2024. - PMC - PubMed
    1. Attwood MM, et al. Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov. 2021;20(11):839–61. - PubMed
    1. Roskoski R Jr.. Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update. Pharmacol Res. 2024;200:107059. - PubMed
    1. Arsenault R, Griebel P, Napper S. Peptide arrays for kinome analysis: new opportunities and remaining challenges. Proteomics. 2011;11(24):4595–609. - PubMed

Publication types

LinkOut - more resources